Gold Standard Diagnostics
Private Company
Funding information not available
Overview
Gold Standard Diagnostics (GSD) is a private, commercial-stage diagnostics company founded in 1991 and headquartered in Budapest, Hungary. It operates as a global network, providing over 2,500 diagnostic assays across 16 key product lines to clients in 62 countries. The company's business model is centered on the development, manufacturing, and commercialization of rapid test kits (ELISA, PCR, Lateral Flow) and associated instruments for bioanalytical testing in non-clinical and clinical markets. GSD is a revenue-generating entity with a strong focus on food safety, environmental monitoring, and animal health diagnostics.
Technology Platform
Integrated diagnostic technologies including Immunoassays (ELISA), Molecular Diagnostics (PCR), Lateral Flow Assays (LFA), and associated automation instruments for bioanalytical testing.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Operates in a crowded field competing against major life science tools companies (e.g., Thermo Fisher, Merck, PerkinElmer) and specialized diagnostic firms (e.g., IDEXX in animal health, Romer Labs in food safety). Differentiation is achieved through a broad multi-technology portfolio, focus on applied industrial markets, integrated workflow solutions, and a global distribution network. Competes on reliability, ease-of-use, and customer-specific customization.